1. Home
  2. AVTX vs PTA Comparison

AVTX vs PTA Comparison

Compare AVTX & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

HOLD

Current Price

$16.51

Market Cap

888.6M

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest

PTA

Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest

HOLD

Current Price

$17.91

Market Cap

984.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVTX
PTA
Founded
2011
2020
Country
United States
United States
Employees
33
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
888.6M
984.4M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
AVTX
PTA
Price
$16.51
$17.91
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$40.57
N/A
AVG Volume (30 Days)
856.9K
217.8K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
8.31%
EPS Growth
72.07
N/A
EPS
N/A
N/A
Revenue
$27,813,137.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2312.27
N/A
52 Week Low
$10.70
$17.52
52 Week High
$24.27
$20.92

Technical Indicators

Market Signals
Indicator
AVTX
PTA
Relative Strength Index (RSI) 39.35 39.11
Support Level $15.29 $17.52
Resistance Level $16.80 $19.61
Average True Range (ATR) 1.00 0.21
MACD -0.20 0.02
Stochastic Oscillator 23.14 41.90

Price Performance

Historical Comparison
AVTX
PTA

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

About PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest

COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its main investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.

Share on Social Networks: